Renal Disease
Nephrology
4
Pipeline Programs
6
Companies
7
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
0
0
1
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
6 companies ranked by most advanced pipeline stage
AstellasChina - Shenyang
1 program1
Tacrolimus - Prograf® twice daily formulationPhase 41 trial
Active Trials
AstraZenecaCAMBRIDGE, United Kingdom
2 programsPre-pricing & reimbursement, incident renal disease cohortN/A1 trial
assessmentN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AstellasTacrolimus - Prograf® twice daily formulation
GuerbetDotarem
Hansa BiopharmaIdeS®
Pfizer200 mg Ceftaroline fosamil
AstraZenecaPre-pricing & reimbursement, incident renal disease cohort
AstraZenecaassessment
AmgenCare Transitions in Renal Disease Patients
Clinical Trials (7)
Total enrollment: 97,577 patients across 7 trials
Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients
Start: Nov 2011Est. completion: Mar 201846 patients
Phase 4Completed
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)
Start: Sep 2009Est. completion: Dec 201013 patients
Phase 3Terminated
Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation
Start: Jun 2015Est. completion: Nov 2017
Phase 1/2Completed
A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects
Start: Feb 2013Est. completion: Nov 201315 patients
Phase 1Completed
OPTIMISE-CKD Study_current Clinical Landscape in Spain
Start: Dec 2024Est. completion: Oct 202591,628 patients
N/ACompleted
A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria
Start: Jul 2023Est. completion: Aug 20242,575 patients
N/ACompleted
Care Transitions in Renal Disease Patients
Start: Mar 2013Est. completion: Dec 20143,300 patients
N/AUnknown
Related Jobs in Nephrology
Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery
AstraZeneca
Sweden - Gothenburg
6d ago
Director, Strategy & Operations-Nephrology Franchise
Biogen
Cambridge, MA
1w ago
$195K - $269K/yr
Associate Director – Nephrology Market Access Strategy
Biogen
Cambridge, MA
1w ago
$164K - $226K/yr
Vice President, Head of Renal Sales
Novartis
Field Non-Sales (USA)
1w ago
$274K - $510K/yr
Medical Science Liaison, CardioRenal - Portland, OR
AstraZeneca
Portland - OR, US
1w ago
Area Sales Manager (Florida Region)
Outset Medical
Florida Region
1w ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
6 companies competing in this space